The first Abbvie trade was made in Q4 2016.
Since then Richard Pzena bought shares seven more times and sold shares on five occasions. The investor sold all their shares in Q1 2025 and doesn't own any shares in Abbvie anymore.
Avg closing price
Price range
Sold -1.67 Thousand shares
Q1 2025
Avg closing price
$193.75
Price range
$169.15
-
$216.66
New holding (+1.67 Thousand shares)
Q4 2024
Avg closing price
$183.81
Price range
$164.95
-
$203.87
Sold -6.34 Thousand shares
Q2 2021
Avg closing price
$112.62
Price range
$105.21
-
$117.21
Increased shares by 1.8% (+111 shares)
Q1 2021
Avg closing price
$106.96
Price range
$102.30
-
$112.62
Increased shares by 2.3% (+138 shares)
Q4 2020
Avg closing price
$96.10
Price range
$80.49
-
$108.67
Sold 15.6% shares (-1.13 Thousand shares)
Q3 2020
Avg closing price
$94.15
Price range
$85.91
-
$100.83
Sold 10.2% shares (-824 shares)
Q2 2020
Avg closing price
$88.05
Price range
$73.37
-
$98.18
Increased shares by 153.2% (+4.87 Thousand shares)
Q1 2020